Hexpol TPE scales up to meet demand for medical-grade thermoplastic elastomers

Hexpol TPE announced today that it will invest SEK 57 million ($5.
6 million) at its plant in Åmål, Sweden, to support the growing demand for thermoplastic elastomers (TPE) to meet changing market demands
.
This investment will expand production capacity and ensure its material portfolio meets product safety standards
.

Hexpol TPE specializes in TPE compounds for sensitive and regulated applications such as medical devices, toys, consumer products, automotive parts and food contact packaging
.
Sustainability and bio-based materials are also drivers of investment, the company said
.

A new facility currently under construction will be dedicated to medical production with stringent controls for cleanliness, traceability and repeatability
.
It has been designed to minimise the risk of contamination and will house a new twin-screw compounding line with gravity feeders and advanced monitoring systems
.
Construction is expected to be completed in fall 2022
.

Hexpol TPE produced the first medical compounds in the 1990s and in 2004 introduced the Mediprene line of TPEs for medical use
.
It was the first TPE compound manufacturer in Europe to be ISO13485 certified in 2007
.

The company added that the project also lays the groundwork for future development, optimizing internal logistics and improving automation and robotics
.

Hepol TPE is headquartered in Malmö, Sweden, and has factories in China, Germany, the UK and the US
.